Ferrlecit (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Ferrlecit drug offered from sanofi-aventis U.S. LLC. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | sodium ferric gluconate complex |
SUBSTANCE NAME: | SODIUM FERRIC GLUCONATE COMPLEX |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-03-01 |
END MARKETING DATE: | 0000-00-00 |
Ferrlecit HUMAN PRESCRIPTION DRUG Details:
Item Description | Ferrlecit from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(mg/mL) |
START MARKETING DATE: | 2011-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0024-2792_d4a8b488-b33f-456d-bb00-4932fe4cebda |
PRODUCT NDC: | 0024-2792 |
APPLICATION NUMBER: | NDA020955 |
Other SODIUM FERRIC GLUCONATE COMPLEX Pharmaceutical Manufacturers / Labelers: